The atovaquone and proguanil drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Atovaquone and proguanil drugs are two combinations of drugs that are given to treat malaria. Malaria is caused by mosquito bites and it is common in many countries of the world. African countries such as Albania, Angola, Burundi, and many parts of South Asia are hard hit by malaria every year as per the guardian. Malaria parasites are there in mosquito bites and they enter the human body after they bite. Parasites make their way into the liver and red blood cells of the body. This drug combination is used to treat and kill parasites present inside various tissues in the human body. In many cases, different medication is taken to treat malaria such as primaquine. Atovaquone and proguanil are taken together so that infections do not return even after treatment. These belong to a drug category which is known as antimalarials.
The efficiency of this drug combination in other diseases is expected to drive the market during the forecast period. For instance, in Dec 2021, A study was conducted by the Aarhus University team which had shown that Atovaquone which is used for the treatment of malaria is effective in the treatment of the latest variant of COVID-19 which is omicron. The research team found that this drug is useful even in previous variants also which are alpha and delta variants. This drug is believed to block infection in human lung cells which happens due to COVID-19. The team of researchers is of the view that this drug would stop the virus to replicate. Two clinical trials have been done earlier in 2021.
Government department of various countries is making their directives on the travel plan to malaria hit regions. For instance, in May 2021, the Center for Disease Control and Prevention (CDC) has given fresh travel guidelines for traveling to major malaria-hit regions. They have provided guidelines for traveling to the Burundi region of Africa which is hit by malaria on a large scale every year. Health officials of the department have stated that people should be careful while traveling to this region and take essential medications with them while traveling to his region. Talking about the drug officials said they should take atovaquone and proguanil daily to prevent malaria from becoming a serious health ailment. Moreover, this drug combination has shown a good result in clinical trials done for babesiosis disease. For instance, in Feb 2022, as per a study published in the Cureus journal, a combination treatment given for babesiosis involves atovaquone and azithromycin. This drug proved effective in babesiosis conditions which are caused by zoonotic protozoa that primarily infect red blood cells. Babesiosis is a rare infection, however, can be life-threatening in some cases.
(Get 15% Discount on Buying this Report)
Get Sample Copy of atovaquone and proguanil drug market at:
https://orionmarketreports.com/request-sample/?id=94076&submit=Request+Sample%0D%0A
Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Top Major Key Players:
GlaxoSmithKline Plc, Mylan NV, and Glenmark Pharmaceuticals Ltd., among others.
A full report of atovaquone and proguanil drug market is available at:
https://orionmarketreports.com/global-atovaquone-and-proguanil-drug-market/94076/
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Atovaquone And Proguanil Drug Market Report by Segment
By Application
Adult
Pediatric
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
